MDR multidrug resistance
MDR multidrug resistance(多药耐药)
MDR (multidrug resistance) is a property that first identified in tumor cell, hat the resistance of tumor cell is to a variety of chemotherapy agent due to active efflux via transporter proteins.
MDR multidrug resistance 相关产品(43)
- GC426167-oxo StaurosporineCAS: 125035-83-8纯度: >98.00%
An antibiotic with diverse biological activities
- GC43060C2 Adamantanyl Globotriaosylceramide (d18:1/2:0)CAS: 261155-87-7纯度: >98.00%
C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain.
- GC44195Milbemycin A4 oximeCAS: 93074-04-5纯度: >99.00% / >98.00%
Milbemycin A4 oxime是一种通过氧化和肟化米尔贝霉素A4制备的半合成大环内酯类化合物，被用于治疗寄生虫相关疾病。
- GC45395Cabazitaxel-d9CAS: 1383572-19-7纯度: >99.00%
An internal standard for the quantification of cabazitaxel
- GC45792Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III)CAS: 39916-28-4纯度: >95.00%
An inducer of ferroptosis
- GC46809Afatinib-d6CAS: 1313874-96-2纯度: >99.00%
An internal standard for the quantification of afatinib
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC17403 | Pyronaridine Tetraphosphate | 76748-86-2 | >98.00% | |
An antimalarial agent | ||||
| GC18901 | CAY10647 | 1253697-49-2 | - | |
An inhibitor of tubulin polymerization and cancer cell growth | ||||
| GC40795 | CAY10503 | 890854-82-7 | >98.00% | |
A proapoptotic, antiproliferative compound | ||||
| GC41564 | MPT0B014 | 1215208-59-5 | >98.00% | |
An inhibitor of tubulin polymerization | ||||
| GC41629 | Piperafizine A | 130603-59-7 | >99.00% | |
A P-glycoprotein inhibitor | ||||
| GC41865 | 10'-Desmethoxystreptonigrin | 136803-89-9 | >95.00% | |
An antibiotic | ||||
| GC42616 | 7-oxo Staurosporine | 125035-83-8 | >98.00% | |
An antibiotic with diverse biological activities | ||||
| GC42806 | Andrastin A | 174232-42-9 | >95.00% | |
A meroterpenoid farnesyltransferase inhibitor | ||||
| GC43004 | C10 Ceramide (d18:1/10:0) | 111122-57-7 | >98.00% | |
A bioactive sphingolipid | ||||
| GC43060 | C2 Adamantanyl Globotriaosylceramide (d18:1/2:0) | 261155-87-7 | >98.00% | |
C2 Adamantanyl globotriaosylceramide (AdaGb3) is a bioactive sphingolipid and water-soluble form of globotriaosylceramide that contains an adamantanyl group in place of the fatty acyl chain. | ||||
| GC44129 | MC 70 | 1031367-64-2 | >98.00% | |
A P-glycoprotein inhibitor | ||||
| GC44195 | Milbemycin A4 oxime | 93074-04-5 | >99.00% / >98.00% | |
Milbemycin A4 oxime是一种通过氧化和肟化米尔贝霉素A4制备的半合成大环内酯类化合物，被用于治疗寄生虫相关疾病。 | ||||
| GC44613 | PF-6274484 | 1035638-91-5 | >98.00% | |
An EGFR inhibitor | ||||
| GC44615 | PGP-4008 | 365565-02-2 | >95.00% | |
A selective P-glycoprotein inhibitor | ||||
| GC44821 | Reversin 121 | 174630-04-7 | >98.00% | |
A hydrophobic peptide chemosensitizer | ||||
| GC45246 | (-)-Chaetominine | 918659-56-0 | >95.00% | |
A cytotoxic alkaloid | ||||
| GC45324 | 2,5-dimethyl Celecoxib | 457639-26-8 | >95.00% | |
An anticancer celecoxib derivative | ||||
| GC45395 | Cabazitaxel-d9 | 1383572-19-7 | >99.00% | |
An internal standard for the quantification of cabazitaxel | ||||
| GC45679 | Carubicin | 50935-04-1 | >98.00% | |
An anthracycline with anticancer activity | ||||
| GC45688 | STX140 | 401600-86-0 | >98.00% | |
An estrogen sulfamate | ||||
| GC45784 | ONT-093 | 216227-54-2 | >98.00% | |
A P-glycoprotein inhibitor | ||||
| GC45792 | Chlorido[N,N'-disalicylidene-1,2-phenylenediamine]iron(III) | 39916-28-4 | >95.00% | |
An inducer of ferroptosis | ||||
| GC46004 | Evoxanthine | 477-82-7 | >95.00% | |
An alkaloid | ||||
| GC46809 | Afatinib-d6 | 1313874-96-2 | >99.00% | |
An internal standard for the quantification of afatinib | ||||